Ignite SD
0
Login
Register
Viewing StudyNCT04298606
Home
Search
Stocks
Certify Doc
Genes
Clinical Trials
CompTox
DrugMatrix
Open Targets
Products
Support
Bugs
eRecord
Main Search
All Studies
All Organizations
Report Bug
View Study With Definitions
Ignite Creation Date:
2024-05-06 @ 2:22 PM
Last Modification Date:
2024-10-26 @ 1:30 PM
Study NCT ID:
NCT04298606
Status:
RECRUITING
Last Update Posted:
2023-08-01
First Post:
2020-03-04
Brief Title:
A Vaccine CIMAvax-EGF for the Prevention of Lung Cancer Development or Recurrence
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Overview
Dates
Organization
Conditions
Design
Enrollment
Locations
Outcomes
Conditions & Keywords Data
Conditions:
Name
Stage IIIA Lung Cancer AJCC v8
Chronic Obstructive Pulmonary Disease
Lung Non-Small Cell Carcinoma
Pneumonia
Stage IB Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Stage IIA Lung Cancer AJCC v8
Stage IIB Lung Cancer AJCC v8
Keywords: